Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a mild skin barrier condition, such as mild to moderate atopic dermatitis (eczema), mild to moderate chronic plaque psoriasis, contact dermatitis, or dry/flaky skin that occurs seasonally or is visibly noticeable
- People whose eczema is considered mild to moderate, meaning their condition scores 50 or below on a standard medical scale, and who are not currently using prescription creams or ointments to manage it
- People whose psoriasis affects a small to moderate portion of the body (roughly 3% to 10% of total body surface area)
- People who have matching test areas available on the inner side of both forearms
- People who are willing and able to give their agreement to participate and follow the study procedures
Who may not be able to join:
- People with severe eczema or psoriasis that requires strong prescription treatments, either taken by mouth/injection or applied to the skin
- People who have used steroid creams, certain immune-suppressing treatments, biologic medications, or light therapy within the past 2 weeks
- People who have open wounds or signs of skin infection at the areas to be tested
- People who are pregnant or breastfeeding
- People who have many moles, tattoos, or thick body hair in the test areas on the forearms
- People who are in poor general health or have a weakened immune system
- People with a known or suspected allergy to the study product, any of its ingredients, or to petrolatum (petroleum jelly)
- People who are unwilling or unable to attend all required visits at the trial site
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Vermen M Verallo Rowell, MD, VMV Skin Research Center & Clinics
Phone: 639171478318
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Transepidermal water loss; Skin hydration; Skin sebum; Skin erythema and pigmentation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.